Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.540
+0.010 (1.89%)
At close: Mar 9, 2026, 4:00 PM EDT
0.560
+0.020 (3.70%)
After-hours: Mar 9, 2026, 4:06 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $39.67 million as of March 9, 2026. Its market cap has decreased by -14.87% in one year.
Market Cap
39.67M
Enterprise Value
-57.57M
1-Year Change
-14.87%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $39.67M, a decrease of -90.70%. That is a compound annual growth rate of -41.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 38.93M | 15.83% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 44.74M |
| Lisata Therapeutics | 44.46M |
| Telomir Pharmaceuticals | 44.01M |
| Lite Strategy | 44.00M |
| CervoMed | 43.95M |
| NextCure | 43.12M |
| Apollomics | 42.49M |
| Aligos Therapeutics | 42.40M |